Skip to content

Clinical trials

Terminated Leukemia, Lymphocytic, Chronic, B-Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Terminated Country / region: Netherlands Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biomea Fusion Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Genmab1
Lakefront Biotherapeutics NV1
Lava Therapeutics1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Leukemia, Myeloid, Acute2
Lymphoma2
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2
Neoplasms2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.